Mcintyre Freedman & Flynn Investment Advisers Inc Abbott Laboratories Transaction History
Mcintyre Freedman & Flynn Investment Advisers Inc
- $134 Billion
- Q4 2024
A detailed history of Mcintyre Freedman & Flynn Investment Advisers Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Mcintyre Freedman & Flynn Investment Advisers Inc holds 2,390 shares of ABT stock, worth $308,477. This represents 0.2% of its overall portfolio holdings.
Number of Shares
2,390
Previous 2,390
-0.0%
Holding current value
$308,477
Previous $272 Million
0.79%
% of portfolio
0.2%
Previous 0.19%
Shares
2 transactions
Others Institutions Holding ABT
# of Institutions
3,247Shares Held
1.31BCall Options Held
8.71MPut Options Held
8.02M-
Vanguard Group Inc Valley Forge, PA168MShares$21.7 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$9.9 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$8.49 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.88 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $226B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...